Search company, investor...
OliX Pharmaceuticals company logo

OliX Pharmaceuticals

olixpharma.com

Founded Year

2010

Stage

IPO | IPO

Date of IPO

7/18/2018

Market Cap

0.12B

Stock Price

18.18

About OliX Pharmaceuticals

OliX Pharmaceuticals (KOSDAQ: 226950) is a biotechnology and pharmaceutical company. The company develops ribonucleic acid interference technology, ribonucleic acid interference therapeutics, and pharmaceuticals for the treatment of macular degeneration. It is based in Suwon-si, South Korea.

Headquarters Location

Ace Gwanggyo Tower 1 No. 1014 17 Daehak4-ro, Yeongtong-gu

Suwon-si, 16226,

South Korea

Missing: OliX Pharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: OliX Pharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

OliX Pharmaceuticals Patents

OliX Pharmaceuticals has filed 19 patents.

The 3 most popular patent topics include:

  • RNA
  • Molecular biology
  • Gene expression
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/12/2018

2/28/2023

MicroRNA, RNA, Molecular biology, DNA, Virus families

Grant

Application Date

2/12/2018

Grant Date

2/28/2023

Title

Related Topics

MicroRNA, RNA, Molecular biology, DNA, Virus families

Status

Grant

OliX Pharmaceuticals Frequently Asked Questions (FAQ)

  • When was OliX Pharmaceuticals founded?

    OliX Pharmaceuticals was founded in 2010.

  • Where is OliX Pharmaceuticals's headquarters?

    OliX Pharmaceuticals's headquarters is located at Ace Gwanggyo Tower 1 No. 1014, Suwon-si.

  • What is OliX Pharmaceuticals's latest funding round?

    OliX Pharmaceuticals's latest funding round is IPO.

  • Who are the investors of OliX Pharmaceuticals?

    Investors of OliX Pharmaceuticals include KIWOOM Investment and Atinum Investment.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.